Neurex Report issue

Contributed to NME For profit Phase 2
Founded: Menlo Park CA United States (1986)
Status: Acquired by Elan Pharmaceuticals (1998) → now Perrigo (2013)

Organization Overview

First Clinical Trial
1999
NCT00002160
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1999

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

ziconotide (prialt) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Pain (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1